2023, Number 1
Considering the best study designs to evaluate healthcare interventions
Language: English
References: 5
Page:
PDF size: 172.27 Kb.
Text Extraction
Regarding the study published by Ramirez-Sevilla et al. in your prestigious journal, we would like to make specific comments:Metabolic syndrome encompasses multiple diseases, such as visceral obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels (HDL-C). Multiple epidemiologic studies and meta-analyses demonstrate the association between Lower urinary tract symptoms and metabolic syndrome, according to its pathogenesis: systemic inflammation and oxidative stress.
In consequence, metabolic syndrome and all its components are risk factors for developing urinary tract infections, and this is a vital population for having the intention to prevent this deleterious condition. Hence, considering any new tool to prevent UTIs might improve these patients’ quality of life. Furthermore, in this study, inclusion criteria are vague and imprecise, and definitions are outdated. Therefore, conclusion might not be applicable nowadays.
REFERENCES
Dobrowolski P, Prejbisz A, Kuryłowicz A, BaskaA, Burchardt P, Chlebus K, et al. Metabolicsyndrome – a new definition and managementguidelines. A joint position paper by the PolishSociety of Hypertension, Polish Society for theTreatment of Obesity, Polish Lipid Association,Polish Association for Study of Liver, PolishSociety of Family Medicine, Polish Society ofLifestyle Medicine, Division of Prevention andEpidemiology Polish Cardiac Society, “Club 30”Polish Cardiac Society, and Division of Metabolicand Bariatric Surgery Society of Polish Surgeons.Arch Med Sci. 2022;18(5):1133–56. doi: https://doi.org/10.5114/aoms/152921